Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 43 articles: HTML format

Single Articles

May 2008
1. PALMA I , Pena RY, Contreras A, Ceballos-Reyes G, et al
   Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation.
   Cancer Lett. 2008;263:204-11.
   PubMed     Related articles    Abstract available
   
   
   
2. TANG B , Yang Z, Huang J, Hao Z, et al
   Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging.
   Cancer Lett. 2008;263:99-106.
   PubMed     Related articles    Abstract available
   
   
   April 2008
3. CHANG HL , Su JH, Yeh YT, Lee YC, et al
   Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
   Cancer Lett. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. CAO C , Lu S, Sowa A, Kivlin R, et al
   Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs.
   Cancer Lett. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. HUANG C , Yang S, Ge R, Sun H, et al
   ZNF23 induces apoptosis in human ovarian cancer cells.
   Cancer Lett. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. CHO JM , Manandhar S, Lee HR, Park HM, et al
   Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
   Cancer Lett. 2008;260.
   PubMed     Related articles    Abstract available
   
   
   
7. WOODS DC , Liu HK, Nishi Y, Yanase T, et al
   Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death.
   Cancer Lett. 2008;260.
   PubMed     Related articles    Abstract available
   
   
   
8. RIGHETTI SC , Perego P, Carenini N, Zunino F, et al
   Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
   Cancer Lett. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
9. CARON D , Savard PE, Doillon CJ, Olivier M, et al
   Protein tyrosine phosphatase inhibition induces anti-tumor activity: Evidence of Cdk2/p27(kip1) and Cdk2/SHP-1 complex formation in human ovarian cancer cells.
   Cancer Lett. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
10. XING H , Weng D, Chen G, Tao W, et al
    Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. NOVAK-HOFER I , Cohrs S, Grunberg J, Friedli A, et al
    Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
12. CLENDENEN TV , Arslan AA, Koenig KL, Enquist K, et al
    Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. PARK SY , Jeong KJ, Lee J, Yoon DS, et al
    Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
    Cancer Lett. 2007;258:63-9.
    PubMed     Related articles    Abstract available
    
    
    November 2007
14. SOUFLA G , Sifakis S, Spandidos DA
    FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
15. PANANI AD
    Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: Is it a common cytogenetic abnormality in cancer?
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
16. SHANKER M , Gopalan B, Patel S, Bocangel D, et al
    Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways.
    Cancer Lett. 2007;254:217-26.
    PubMed     Related articles    Abstract available
    
    
    August 2007
17. LI X , Ye F, Chen H, Lu W, et al
    Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta.
    Cancer Lett. 2007;253:144-53.
    PubMed     Related articles    Abstract available
    
    
    
18. MORENO M , Bontkes HJ, Scheper RJ, Kenemans P, et al
    High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
19. MALKI S , Bibeau F, Notarnicola C, Roques S, et al
    Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
20. ZOU W , Yang H, Hou X, Zhang W, et al
    Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
    Cancer Lett. 2007;248:211-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
21. SCHOLLER N , Garvik B, Hayden-Ledbetter M, Kline T, et al
    Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.
    Cancer Lett. 2007;247:130-6.
    PubMed     Related articles    Abstract available
    
    
    February 2007
22. ROBERTSON DM , Pruysers E, Jobling T
    Inhibin as a diagnostic marker for ovarian cancer.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
23. NAKAI H , Watanabe Y, Ueda H, Hoshiai H, et al
    Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. PONNUSAMY MP , Venkatraman G, Singh AP, Chauhan SC, et al
    Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.
    Cancer Lett. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
25. YE B , Aponte M, Dai Y, Li L, et al
    Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
26. NAGLE CM , Chenevix-Trench G, Webb PM, Spurdle AB, et al
    Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
27. WANG B , Chen G, Zhou J, Wu P, et al
    Deletion of the intracellular domain of coxsackie and adenovirus receptor (CAR) enhances the expression of itself and boosts the efficiency of current adenovirus-mediated gene therapy in ovarian cancer cell lines in vitro.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
28. SADZUKA Y , Tokutomi K, Iwasaki F, Sugiyama I, et al
    The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
    Cancer Lett. 2006;241:42-8.
    PubMed     Related articles    Abstract available
    
    
    May 2006
29. ROSEN EM , Fan S, Ma Y
    BRCA1 regulation of transcription.
    Cancer Lett. 2006;236:175-85.
    PubMed     Related articles    Abstract available
    
    
    
30. COSTA S , Pinto D, Pereira D, Vasconcelos A, et al
    Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
31. LIU MC , Choong DY, Hooi CS, Williams LH, et al
    Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
32. NOSKE A , Kaszubiak A, Weichert W, Sers C, et al
    Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: Increased expression of AKT in advanced ovarian cancer.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
33. HECTOR S , Nava ME, Clark K, Murphy M, et al
    Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    February 2006
34. PAPAZISIS KT , Kalemi TG, Zambouli D, Geromichalos GD, et al
    Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro.
    Cancer Lett. 2006;233:255-64.
    PubMed     Related articles    Abstract available
    
    
    
35. LISCOVITCH M , Ravid D
    A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
36. UENO Y , Enomoto T, Otsuki Y, Sugita N, et al
    Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.
    Cancer Lett. 2006;.
    PubMed     Related articles    Abstract available
    
    
    December 2005
37. DONG P , Nabeshima K, Nishimura N, Kawakami T, et al
    Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas.
    Cancer Lett. 2005;.
    PubMed     Related articles    Abstract available
    
    
    
38. STOECK A , Schlich S, Issa Y, Gschwend V, et al
    L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.
    Cancer Lett. 2005;.
    PubMed     Related articles    Abstract available
    
    
    
39. WAKANA K , Akiyama Y, Aso T, Yuasa Y, et al
    Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis.
    Cancer Lett 2005;.
    PubMed     Related articles    Abstract available
    
    
    August 2005
40. BOGUSIEWICZ M , Semczuk A, Gogacz M, Skomra D, et al
    Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas.
    Cancer Lett 2005;.
    PubMed     Related articles    Abstract available
    
    
    June 2005
41. SUROWIAK P , Materna V, Denkert C, Kaplenko I, et al
    Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers.
    Cancer Lett 2005;.
    PubMed     Related articles    Abstract available
    
    
    May 2005
42. MOLTENI M , Marabella D, Orlandi C, Rossetti C, et al
    Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4.
    Cancer Lett 2005;.
    PubMed     Related articles    Abstract available
    
    
    
43. SANCHEZ M , Torres JV, Tormos C, Iradi A, et al
    Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2'-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community.
    Cancer Lett 2005;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: